8 completed, 1 terminated. 5 Phase 3, 2 Phase 4, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 4, Terminated 1 |
| Phase 4 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Eyenovia Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Fixed Combination Phenylephrine-Tropicamide for Pupil Dilation MydCombi - Mydriasis | Phase 4 | Completed | Eyenovia Inc. | 30 | 2023-11-28 | 2024-04-18 |
| Safety & Efficacy of Pilocarpine Ophthalmic Spray for Temporary Improvement of Near Vision in Presbyopic Adults Pilocarpine Ophthalmic administered with the Optejet dispenser, Placebo administered with the Optejet dispenser - Presbyopia | Phase 3 | Completed | Eyenovia Inc. | 145 | 2021-11-03 | 2023-09-11 |
| Evaluation of Pupil Dilation Speed With the MAP Dispenser tropicamide-phenylephrine fixed combination ophthalmic solution - Mydriasis | Phase 4 | Completed | Eyenovia Inc. | 61 | 2021-05-24 | 2025-01-09 |
| Safety & Efficacy of Pilocarpine Eye Solutions for Temporary Improvement of Near Vision in Presbyopic Adults Pilocarpine Ophthalmic, Placebo - Presbyopia | Phase 3 | Completed | Eyenovia Inc. | 84 | 2020-12-15 | 2021-08-09 |
| Microdosed Atropine 0.1% and 0.01% Ophthalmic Solutions for Reduction of Pediatric Myopia Progression Atropine 0.1% Ophthalmic Solution, Atropine 0.01% Ophthalmic Solution, Placebo Ophthalmic Solution - Myopia | Phase 3 | Terminated | Eyenovia Inc. | 438 | 2019-06-03 | 2025-01-06 |
| Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation Tropicamide/Phenylephrine ophthalmic solution (TR/PE), Placebo - Mydriasis | Phase 3 | Completed | Eyenovia Inc. | 76 | 2018-12-01 | 2022-03-18 |
| Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation Tropicamide 1%-Phenylephrine 2.5% ophthalmic solution (TR/PE), Tropicamide 1% ophthalmic solution (TR), Phenylephrine 2.5% ophthalmic solution (PE) - Mydriasis | Phase 3 | Completed | Eyenovia Inc. | 70 | 2018-11-15 | 2022-03-18 |
| Eyenovia MiDD Usability Study Latanoprost - Intraocular Pressure | Not applicable | Completed | Eyenovia Inc. | 30 | 2018-03-12 | 2018-07-26 |
| Study of the Safety, Efficacy and PK of EYN-1601 in Dilation of the Pupil MDD-administered EYN-1601, Phenylephrine 2.5% Eyedrop, Phenylephrine 10% Eyedrop - Mydriasis | Phase 2 | Completed | Eyenovia Inc. | 12 | 2016-10-01 | 2022-07-27 |
Mydriasis (5) · Presbyopia (2) · Myopia (1)
Ophthalmic Solutions (3) · Tropicamide (3) · Phenylephrine (2) · Atropine (1) · Latanoprost (1)
United States (7) · Mexico (1) · Panama (1)
Tsontcho Ianchulev, MD, MPH (3) · Ernesto Calvo, MD (1) · Greg Bennett, MS (1) · Reuben Orillac, MD (1)